Fusarium verticillioides fungemia in a liver transplantation patient: successful treatment with voriconazole

Stefania Cocchi; Mauro Codeluppi; Claudia Venturelli; Andrea Bedini; Antonella Grottola; William Gennari; Francesca Cavrini; Fabrizio Di Benedetto; Nicola De Ruvo; Fabio Rumpianesi; Giorgio Enrico Gerunda; Giovanni Guaraldi

doi:10.1016/j.diagmicrobio.2011.08.024

Fusarium verticillioides fungemia in a liver transplantation patient: successful treatment with voriconazole

Diagn Microbiol Infect Dis. 2011 Dec;71(4):438-41. doi: 10.1016/j.diagmicrobio.2011.08.024.

Authors

Stefania Cocchi¹, Mauro Codeluppi, Claudia Venturelli, Andrea Bedini, Antonella Grottola, William Gennari, Francesca Cavrini, Fabrizio Di Benedetto, Nicola De Ruvo, Fabio Rumpianesi, Giorgio Enrico Gerunda, Giovanni Guaraldi

Affiliation

¹ Clinic of Infectious Diseases, Department of Medicine and Medical Specialities, Microbiology and Virology Laboratories, University of Modena and Reggio Emilia, Azienda Ospedaliero-Universitaria Policlinico, Modena, Italy. [email protected]

PMID: 22083080
DOI: 10.1016/j.diagmicrobio.2011.08.024

Abstract

Fusarium is an opportunistic fungal pathogen which is emerging as a significant cause of morbidity and mortality in immunocompromised hosts. We present a rare case of F. verticillioides fungemia that occurred in a patient who underwent a second orthotopic liver transplantation for chronic rejection and completely responded to treatment with voriconazole.

Publication types

Case Reports

MeSH terms

Adult
Antifungal Agents / administration & dosage
Female
Fungemia / diagnosis*
Fungemia / drug therapy*
Fusariosis / diagnosis*
Fusariosis / drug therapy*
Fusarium / isolation & purification*
Humans
Immunocompromised Host
Liver Transplantation / adverse effects*
Pyrimidines / administration & dosage*
Treatment Outcome
Triazoles / administration & dosage*
Voriconazole

Substances

Antifungal Agents
Pyrimidines
Triazoles
Voriconazole